Health Condition 1: K053- Chronic periodontitis
Conditions
Interventions
Intervention1: Hyaluronic acid (HA) is a FDA approved.: Formed by disaccharide units, is non-immunogenic, enzymatically degradable and relatively non adhesive to cells and proteins and capable of inte
Sponsors
Institute of Dental Studies and Technologies
Eligibility
Inclusion criteria
Inclusion criteria: • Patients in good general health • Patients with at least one Type I or II (Norland and Tarnowâ??s classification)7 deficient papilla in anterior region • Well aligned maxillary teeth, no spacing, no crowding or intrusion or extrusion.
Exclusion criteria
Exclusion criteria: • Pregnant and lactating mothers • History of tobacco consumption. • History of taking any medications which are known to increase the risk of gingival hyperplasia. • Any artificial crown, proximal cervical restoration or abrasion of maxillary anterior teeth. • Any known allergy with hyaluronic acid • Patients with history of traumatic oral hygiene measures or periodontal surgeries over the last 6 months at the area of interest
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2. Clinical measurement: distance from the contact point (CP) to papillary tip using the prepared stent 3. Photographic measurement: 4. Radiographic measurement. The following distances will be measured a. Distance from CP to crest of the bone (BC) b. Interdental width at the level of facial CEJ Timepoint: follow up at 15th day, 1, 2, 3,4,5,6 months and the clinical and photographic parameters will be re-recorded | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. A questionnaire for assessment of patientâ??s response including questions regarding patientâ??s assessment of black triangleTimepoint: First day of treatment and after 6 months | — |
Countries
India
Contacts
Public ContactDr Manish Khatri
Institute of Dental Studies and Technologies
Outcome results
None listed